Young A C, Zhang W, Sacchettini J C, Nathenson S G
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Cancer Surv. 1995;22:17-36.
The recent crystal structure determinations of MHC class I molecules with single bound peptides have allowed us to understand the guidelines that govern peptide binding in a given MHC allele. Evolution has provided for MHC class I molecules whose antigen binding clefts possess distinct physical and chemical properties as a result of the particular arrangement of variable residues lining the binding cleft. As a result, a given molecule binds a unique set of peptides, the position and identity of whose anchor residues are dictated by the features of the cleft. In addition to the interactions between the anchor residues and the cleft, the peptide is held in the groove by a highly conserved array of hydrogen bonds. A tantalizing application of our newfound understanding of peptide binding will be in the design of model peptides that either block or enhance immune response, in order to achieve effective treatments for a variety of disorders of the immune system.
近期对结合单个肽段的MHC I类分子的晶体结构测定,使我们得以了解在特定MHC等位基因中支配肽段结合的准则。进化产生了MHC I类分子,其抗原结合裂隙由于结合裂隙内衬可变残基的特定排列而具有独特的物理和化学性质。因此,给定的分子结合一组独特的肽段,其锚定残基的位置和身份由裂隙的特征决定。除了锚定残基与裂隙之间的相互作用外,肽段还通过一系列高度保守的氢键保持在沟槽中。我们对肽段结合新获得的理解的一个诱人应用将是设计能够阻断或增强免疫反应的模型肽,以便实现对各种免疫系统疾病的有效治疗。